Lataa...
Considerations in the development of generic disease therapies for multiple sclerosis
PURPOSE OF REVIEW: Medication prices are a major contributor to the high cost of care for multiple sclerosis (MS). The patents for some of the initial injectable therapies for relapsing MS recently expired, permitting development, regulatory approval, and marketing of generic alternatives with the p...
Tallennettuna:
| Julkaisussa: | Neurol Clin Pract |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4987120/ https://ncbi.nlm.nih.gov/pubmed/27574572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/CPJ.0000000000000267 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|